ADVERTISEMENT

 

Press Releases

 

13

Jul

2022

New Federal Guidance confuses an already complicated landscape for pharmacists

Author: James Keagy

Today, in response to the U.S. Supreme Court recent decision in Dobbs v Jackson Women’s Health Organization, the U.S. Department of Health and Human Services’ Office for Civil Rights (OCR) released guidance for pharmacies that sets forth their obligations under federal civil rights laws, conflicting with some state laws, and raises concerns for our nation's pharmacies and pharmacists.

Comments (0)
Number of views (10099)
Article rating: No rating

6

Jul

2022

Breaking: FDA permits pharmacists to prescribe Paxlovid to treat COVID-19

Author: James Keagy

Today, after months of effort by APhA and other stakeholders, FDA has updated the EUA for the COVID-19 oral antiviral, Paxlovid, to permit pharmacists to order and prescribe Paxlovid under certain conditions.

Comments (0)
Number of views (17591)
Article rating: No rating

2

Jun

2022

APhA Changes Executive Leadership

Ilisa Bernstein appointed Interim CEO

The Board of Trustees of the American Pharmacists Association announced today that Ilisa Bernstein, PharmD, JD, FAPhA, has been named Interim CEO, effective immediately. Bernstein’s appointment follows the departure of Scott Knoer, PharmD, MS, as Executive Vice-President and CEO.

Comments (0)
Number of views (18628)
Article rating: No rating

26

May

2022

APhA statement on Texas Mass Shooting

WASHINGTON, DC—The American Pharmacists Association (APhA) is deeply saddened by the horrific mass shooting in Uvalde, Texas, elementary school in which a gunman took the lives of at least 19 young children and two dedicated teachers.

Comments (0)
Number of views (3473)
Article rating: No rating

16

Feb

2022

APhA congratulates Robert Califf, MD, on confirmation as FDA Commissioner

Author: Renee Kalu

WASHINGTON, D.C.—The American Pharmacists Association (APhA) issued the following statement to congratulate Robert Califf, MD, on his confirmation to serve once again as commissioner of FDA. APhA looks forward to working with both Califf and the FDA to ensure the safety, efficacy, and security of medications for our nation’s pharmacy patients.

Comments (0)
Number of views (3652)
Article rating: No rating
RSS
First1314151617181921
Advertisement
Advertisement
Advertisement
Advertisement
ADVERTISEMENT